UnitedHealth Group Incorporated $UNH Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 30.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 973,563 shares of the healthcare conglomerate’s stock after acquiring an additional 224,397 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in UnitedHealth Group were worth $357,376,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Lakeshore Capital Group Inc. lifted its position in shares of UnitedHealth Group by 7.9% in the third quarter. Lakeshore Capital Group Inc. now owns 2,648 shares of the healthcare conglomerate’s stock valued at $972,000 after acquiring an additional 194 shares in the last quarter. Rare Wolf Capital LLC grew its position in shares of UnitedHealth Group by 1.4% during the third quarter. Rare Wolf Capital LLC now owns 7,670 shares of the healthcare conglomerate’s stock worth $2,816,000 after purchasing an additional 107 shares in the last quarter. Provident Wealth Management LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $263,000. Redwood Family Wealth LLC raised its stake in UnitedHealth Group by 46.2% during the 3rd quarter. Redwood Family Wealth LLC now owns 3,189 shares of the healthcare conglomerate’s stock valued at $1,171,000 after purchasing an additional 1,007 shares during the period. Finally, Briaud Financial Planning Inc purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $212,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Up 3.2%

NYSE UNH opened at $419.70 on Wednesday. The stock has a 50 day moving average price of $387.40 and a 200-day moving average price of $387.49. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The company has a market capitalization of $376.72 billion, a P/E ratio of 23.97, a P/E/G ratio of 1.47 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. The company had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group’s payout ratio is 53.00%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: A Seeking Alpha analyst initiated coverage with a Strong Buy rating and a $533 price target, citing margin recovery, improved Optum Health contracts and AI-related efficiencies as potential drivers of double-digit EPS growth through 2028. The analyst also viewed UNH’s valuation as discounted relative to the healthcare sector. UnitedHealth: Optum’s Recovery Supports My Strong Buy Rating
• Positive Sentiment: UnitedHealth was selected as a CNBC “Final Trades” stock after its better-than-expected quarterly results, adding to favorable short-term investor sentiment. Twilio, Transocean and a Health Care Stock on CNBC’s Final Trades
• Positive Sentiment: Analysts and investors are reassessing UNH after the earnings beat and raised outlook, while commentary suggests the stock’s recent momentum reflects renewed confidence in medical-cost trends and operational execution. UnitedHealth Group Has The Market Asking A Bigger Question
• Neutral Sentiment: UnitedHealth’s results have renewed interest in healthcare ETFs with UNH exposure, although diversification may reduce the impact of company-specific gains and limit direct upside. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: A competing analyst downgraded UNH from Strong Buy to Buy, arguing that the shares may already reflect much of the recovery at roughly 20 times forward earnings. Valuation, medical-cost pressure and execution risks remain concerns. UnitedHealth: My Thesis Has Played Out, I Wouldn’t Chase Here
• Negative Sentiment: Reports of rising healthcare costs, reduced services and higher prescription-drug prices for older Americans could increase political scrutiny and pressure insurers’ affordability and retention metrics. Older Americans Brace for Higher Healthcare Costs Ahead of Midterms
• Negative Sentiment: Declining individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans highlight regulatory, membership and pricing risks for the broader insurance industry, including UNH. 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027

Analyst Ratings Changes

A number of brokerages have issued reports on UNH. Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a report on Friday, July 17th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Piper Sandler upped their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 14th. Argus raised their target price on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $463.57.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.